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Background: We aimed to investigate the current prevalence of sexual dysfunction (SD), 
mood, anxiety, and personality disorders in female patients with fibromyalgia (FM).
Methods: This case–control study involved 96 patients with FM and 94 healthy women. The SD 
diagnosis was based on a psychiatric interview in accordance with the Diagnostic and Statistical 
Manual of Mental Disorders, fourth edition criteria. Mood and anxiety disorders were diagnosed 
using the Structured Clinical Interview. Personality disorders were diagnosed according to the 
Structured Clinical Interview for DSM, Revised Third Edition Personality Disorders.
Results: Fifty of the 96 patients (52.1%) suffered from SD. The most common SD was lack of 
sexual desire (n=36, 37.5%) and arousal disorder (n=10, 10.4%). Of the 96 patients, 45 (46.9%) 
had a mood or anxiety disorder and 13 (13.5%) had a personality disorder. The most common 
mood, anxiety, and personality disorders were major depression (26%), generalized anxiety 
disorder (8.3%), and histrionic personality disorder (10.4%).
Conclusion: SD, mood, and anxiety disorders are frequently observed in female patients with 
FM. Pain plays a greater role in the development of SD in female patients with FM.
Keywords: anxiety, depression, fibromyalgia, sexual dysfunction
Introduction
Sexual dysfunction (SD) is a major public health problem that affects females more 
than males.1–4 Female SD includes lack of sexual desire, sexual aversion, orgasmic 
disorder, and dyspareunia.5 Epidemiological studies indicate that 30%–50% of women 
complain of SD.2,6 Female SD is composed of several medical and psychosocial com-
ponents7 and is also associated with pathological states, including chronic pain.8 A high 
incidence of SD has been reported in patients with fibromyalgia (FM), compared to 
that in healthy controls.9–13 The development of SD in patients with FM is related to 
several factors, such as pain, fatigue, stiffness, functional disorders, negative body 
image, sexual abuse, and drug therapy.14
FM is a chronic musculoskeletal pain syndrome of unknown etiology characterized 
by widespread body pain and fatigue.15 FM has been identified by the American College 
of Rheumatology as a condition of chronic (.3 months) widespread pain perceived 
on palpitation of at least eleven of 18 tender point sites throughout the body.16 Other 
complaints frequently reported by patients with FM include sleep disorders, anxiety, 
depression, concentration problems, headache, numbness, and tingling.17 FM has 2% 
prevalence in the community and occurs at a four- to sevenfold greater prevalence in 
women than in men.18,19 The prevalence of FM increases with age and is seen more 
frequently during or around menopause.20
Psychiatric disorders are observed frequently in patients with FM.21–26 In particular, 
a significant proportion of patients with FM present with depression. The lifetime 
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prevalence of depression in patients with FM is 50%–70%, 
compared to the spontaneous prevalence rate of 18%–36%.27–29 
Previous studies have justified including major depressive 
symptoms in scales for diagnosing depression.27–29 However, 
a limited number of studies have used a semistructured 
psychiatric interview. Uguz et al30 used the Structured 
Clinical Interview for the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition (DSM-IV) Axis I 
disorders (SCID-I) and reported that 47.6% of patients had 
a psychiatric disorder and 14.6% presented with major 
depression.
A few studies have examined the relationship between 
SD and FM, but they also had significant limitations. SD and 
comorbid mood and anxiety disorders have been detected 
in most studies using only scales. Thus, these studies can 
only provide information about symptoms related to SD and 
accompanying depressive symptoms and anxiety, and they 
do not provide information on the type of SD or the type 
of psychiatric disorder. Furthermore, the studies that have 
used a structured psychiatric interview were carried out with 
a limited number of patients. The personality disorders in 
patients with FM that may lead to SD and an Axis I psychi-
atric disorder have not been assessed previously together.
In this study, we investigated the relationships between 
SD and mood, anxiety, and personality disorders, as well 
as their effects on quality of life in patients with FM. This 
is the first study to evaluate this combination of factors in 
patients with FM.
Methods
This study included 125 female patients diagnosed with FM 
according to the American College of Rheumatology criteria 
who were admitted to the outpatient Physical Therapy Unit 
of Mevlana University School of Medicine. Patients who 
met the inclusion criteria were enrolled in the study after 
providing written and verbal consent.
The inclusion criteria were 1) $18 years of age; 2) mar-
ried; and 3) no use of psychotropic drugs, such as antide-
pressant, anxiolytic, or antipsychotic drugs, in the previous 
3 months for any reason.
The exclusion criteria were 1) ,18 years of age; 2) meno-
pausal; 3) history of urologic surgery; 4) use of medication 
for a chronic medical illness; 5) mental retardation; 6) history 
and current diagnosis of a psychiatric disorder; and 7) use 
of psychotropic drugs, such as antidepressant or anxiolytic 
drugs, in the past 3 months for any reason.
Of the 125 enrolled patients with FM, 15 were excluded 
due to the continued use of psychotropic drugs, five patients 
due to chronic medical condition, and two patients because 
of a history of pelvic surgery; seven patients did not want 
to participate in the study. The final study group consisted 
of 96 patients with FM. The control group consisted of 
94 female volunteers from the general population who 
met the inclusion and exclusion criteria and had not been 
diagnosed with FM or chronic pain but matched the patient 
cohort in sociodemographic characteristics.
This study was approved by the Ethics Committee of 
Mevlana University. The characteristics and procedures of 
the study were explained to the study participants, and oral 
and written informed consent was obtained from all of the 
participants. The sociodemographic and FM characteristics of 
the patients were recorded using a semistructured question-
naire developed by the authors. FM diagnoses were made 
based on the American College of Rheumatology criteria.16 
The visual analog scale (VAS) was used to determine the 
pain intensity.31 Once the sociodemographic characteristics 
of the patients were recorded, they were referred to the 
Psychiatric Outpatient Clinic where psychiatric disorders 
and SD diagnoses were made after a psychiatric interview. 
Psychiatrists, who were blinded to the rheumatological con-
ditions of the patients, evaluated the patients for mood and 
anxiety disorders using the clinical version of the SCID-I.32 
Personality disorders were diagnosed with the Structured 
Clinical Interview for DSM, Revised Third Edition Per-
sonality Disorders.33 The SD diagnosis was made through a 
psychiatric interview and was based on the criteria stated in 
the DSM-IV. The Hamilton Depression Rating Scale34 and 
the Hamilton Anxiety Rating Scale35 were used to determine 
levels of depression and anxiety, respectively.
SPSS Version 16.0 for Windows software (SPSS Inc., 
Chicago, IL, USA) was used for the data analysis. Normality 
of the data distributions was checked with the Kolmogorov–
Smirnov test. The chi-square or Fisher’s exact test was 
applied to compare categorical variables. The t-test or 
the Mann–Whitney U-test was used to analyze numerical 
variables. A multivariate binary logistic regression analysis 
was conducted to determine independent factors associ-
ated with SD. A two-tailed P-value ,0.05 was considered 
significant.
Results
The mean age of the participants (n=190) was 37.75±6.24 years. 
The majority of women were unemployed (n=172, 90.5%), 
and the mean number of years of education was 7.45±3.38. 
No differences were detected in sociodemographic character-
istics between the patient and the control groups (Table 1).
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Table 2 shows the distribution of SD among the patients 
with FM and control subjects. According to the DSM-IV 
criteria, 46 patients (47.9%) were diagnosed with SD. 
The most common SDs in patients with FM were lack of 
sexual desire (n=36, 37.5%) and arousal disorder (n=10, 
10.4%). The categories of presence of any SD (P=0.000), 
sexual desire (P=0.000), orgasm disorder (P=0.033), and 
arousal disorder (P=0.049) were observed significantly 
more frequently in the patient group than in the control 
group. No significant differences in the categories of sexual 
aversion disorder or dyspareunia were detected between 
the groups.
Table 2 shows the distribution of psychiatric and per-
sonality disorders among the patients with FM and control 
subjects. Among the patients with FM, 45 (46.9%) met the 
minimum criteria for a mood or anxiety disorder based on 
the SCID-I. Additionally, 27 patients with FM (28.1%) had 
a mood disorder, and 18 (18.8%) had an anxiety disorder. 
The most common psychiatric disorders were major depres-
sion (n=25, 26%) and generalized anxiety disorder (GAD) 
(n=8, 8.3%), and the incidence rates of these disorders were 
significantly higher in the patient group than those in the 
controls. No significant differences were observed in the 
Table 1 Sociodemographic features and HDRS and HARS scores
Patient  
group
Control  
group
P-value
Age (years) mean ± stdD 38.27±6.18 37.23±6.29 0.214a
Education (years) mean ± stdD 7.06±3.22 7.85±3.51 0.095a
Employment status, n (%)
Unemployed 84 (87.5) 88 (93.6) 0.215b
hDrs, mean ± stdD 7.91±4.10 3.04±1.83 0.000a
hars, mean ± stdD 10.83±6.55 5.80±4.90 0.000a
Notes: aMann–Whitney U-test. bFisher’s exact test.
Abbreviations: HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety 
Rating Scale; StdD, standard deviation.
Table 2 Current prevalence rate of SD, mood, anxiety, and personality disorders in the study groups
Patient group, n=96 Control group, n=94 Odds ratio (95% CI) P-value
any sexual dysfunction 46 (47.9) 12 (12.8) 0.15 (0.07–0.32) 0.000a
sexual desire disorder 36 (37.5) 13 (13.8) 0.26 (0.13–0.54) 0.000a
Orgasm disorder 7 (7.3) 1 (1.1) 0.13 (0.01–1.13) 0.033a
arousal disorder 10 (10.4) 3 (3.2) 0.28 (0.07–1.06) 0.049a
sexual aversion 1 (1) 0 0.99 (0.96–1.10) 1.000b
Dyspareunia 4 (4.2) 1 (1.1) 0.24 (0.02–2.25) 0.368b
any mood disorder 27 (28.1) 2 (2.1) 0.05 (0.01–0.24) 0.000a
Major depression 25 (26) 2 (2.1) 0.06 (0.01–0.26) 0.000b
Dysthymic disorder 2 (2.1) 0 0.97 (0.95–1.00) 0.497b
Bipolar disorder 0 0 – –
any anxiety disorder 18 (18.8) 4 (4.3) 0.19 (0.06–0.59) 0.002a
Generalized anxiety disorder 8 (8.3) 1 (1.1) 0.11 (0.01–0.96) 0.035b
Panic disorder 2 (2.1) 1 (1.1) 0.50 (0.04–5.66) 1.000b
Social phobia 2 (2.1) 1 (1.1) 0.50 (0.04–5.66) 1.000b
Specific phobia 3 (3.1) 2 (2.1) 0.67 (0.11–4.12) 1.000b
Posttraumatic stress disorder 0 0 – –
Not otherwise specified anxiety disorder 6 (6.2) 1 (1.1) 0.16 (0.04–1.36) 0.118b
Obsessive–compulsive disorder 2 (2.1) 1 (1.1) 0.50 (0.04–5.66) 1.000b
any mood or anxiety disorder 45 (46.9) 5 (5.3) 0.06 (0.02–0.17) 0.000b
any axis ii disorder 13 (13.5) 5 (5.3) 0.35 (0.12–1.05) 0.053a
avoidant 2 (2.1) 0 0.97 (0.95–1.00) 0.497b
Dependent 2 (2.1) 1 (1.1) 0.50 (0.04–5.66) 1.000b
Obsessive compulsive 1 (1) 2 (2.1) 2.06 (0.18–23.16) 0.619b
Passive–aggressive 2 (2.1) 0 0.97 (0.95–1.00) 0.497b
Paranoid 0 0 – –
Schizotypal 0 0 – –
Schizoid 0 0 – –
histrionic 10 (10.4) 1 (1.1) 0.09 (0.01–0.73) 0.006a
Borderline 0 0 – –
Narcissistic 0 0 – –
antisocial 0 0 – –
Comorbidity of any psychiatric and personality disorder 10 (10.4) 2 (2.1) 0.18 (0.04–0.87) 0.019a
Notes: aχ2 test. bFisher’s exact test. Values shown in bold are statistically significant.
Abbreviations: SD, sexual dysfunction; CI, confidence interval.
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frequencies of dysthymic disorder, panic disorder, obsessive–
compulsive disorder (OCD), a specific phobia, or social 
anxiety disorder between the patient and the control groups. 
None of the participants had posttraumatic stress disorder or 
a bipolar disorder (Table 2).
Among the patients with FM, 13 (13.5%) had a personality 
disorder. Specifically, histrionic personality disorder was the 
most common personality disorder among patients with FM 
(n=10, 10.4%) and was significantly more prevalent in the 
patient group than in the control group (P=0.006). No signifi-
cant difference in the incidence of any personality disorder was 
observed between the two groups. Similarly, no differences in 
paranoid, schizoid, schizotypal, borderline, narcissistic, or anti-
social personality disorder were observed between the groups 
(Table 2). The incidence of coexistence of any psychiatric and 
any personality disorder was 10.4% (10) in patients with FM, 
and it is higher than the control group (P=0.019).
SD was more frequently seen in patients with a low edu-
cation level when sociodemographic data were compared in 
patients with FM, with and without SD (P=0.012; Table 3). 
The relationships between psychiatric disorders and SD in 
patients with FM are shown in Table 4. Patients with FM 
and SD had a significantly higher incidence of a psychiat-
ric disorder (P=0.001) and an anxiety disorder (P=0.022). 
Specifically, the most common psychiatric disorders were 
major depression (n=14, 30.4%), not otherwise specified 
anxiety disorders (n=6, 13%), and GAD (n=4, 8.7%). Patients 
with FM and reduced sexual desire were significantly more 
frequently diagnosed with a psychiatric disorder (P=0.001), an 
anxiety disorder (P=0.022), a not otherwise specified anxiety 
disorder (P=0.002), or a specific phobia (P=0.023). Patients 
with FM and sexual aversion disorder also had a significantly 
higher incidence of OCD (P=0.021), whereas patients with 
FM and dyspareunia had a significantly higher incidence of 
GAD (P=0.034).
No significant relationship was found between patients 
with FM and SD and a personality disorder (P=0.891). 
Specifically, patients with FM and sexual aversion disorder 
were significantly more frequently diagnosed with avoidant 
personality disorder (P=0.021) and dependent personality 
disorder (P=0.021).
A multivariate logistics regression analysis revealed 
that VAS (Wald x2=4.95, standard error [SE], 0.27; odds 
ratio [OR], 1.816; P=0.026) was an independent variable 
for SD. Any psychiatric disorder (Wald x2=0.218; SE, 
0.83; OR, 1.477; P=0.641), any anxiety disorder (Wald 
x2=3.38; SE, 1.41; OR, 0.074; P=0.066), education (Wald 
x2=1.04; SE, 0.99; OR, 0.904; P=0.308), age (Wald x2=3:55; 
SE, 0.53; OR, 1.104; P=0.059), and Hamilton Anxiety Rating 
Scale (Wald x2=0.33; SE, 0.88; OR, 0.984; P=0.855) were 
not independent factors.
Discussion
This is the first study to evaluate SD and mood, anxiety, 
and personality disorders in female patients with FM. The 
prevalence of any SD disorder was 47.9% in our study, 
and this value was significantly higher in the patient cohort 
than that in the control group (12.8%). Many studies have 
investigated the association between SD and FM.9–12,17,36–40 
da Costa et al36 reported that patients with FM resort to 
significant modifications in their sexual activities and expe-
rience difficulties with orgasm. Shaver et al9 conducted 
telephone interviews to study SD in 442 patients with FM 
and 205 controls and reported that sexual arousal and orgasm 
decreased in patients with FM and that the patients experi-
enced pain during intercourse. Female Sexual Function Index 
scores are lower in patients with FM than those in the control 
group.11,12,40 The important feature of our study was that none 
of the patients with FM included in the study were treated 
with psychotropic regimen. As might be expected, most 
of the psychotropic drugs may lead to SD as a side effect. 
However, there were no clear clinical data regarding the use 
of psychotropic drugs in such patients in previous studies.
We found that patients with FM who had impaired 
sexual function also had a lower educational level. Similarly, 
Prins et al38 reported that patients with FM and SD had a lower 
educational level those in the control group. However, several 
studies have reported no effect of educational level on SD.10,40 
In our study, we found a significant relationship between SD 
and pain intensity on the VAS in patients with FM. VAS 
scores in patients with FM and SD were higher than those 
Table 3 Sociodemographic features and HDRS, HARS, and VAS 
scores in patients with/without sD
Patients with  
SD (mean ± StdD)
Patients without  
SD (mean ± StdD)
P-valuea
Age (years) 36.92±7 39.73±4.80 0.060
education  
(years)
6.34±2.94 7.72±3.35 0.012
Duration of  
FM (months)
52.95±41.74 49.44±37.41 0.953
hDrs 8.45±4.09 7.42±4.08 0.204
hars 12.43±6.45 9.36±6.35 0.007
Vas 7.21±1.26 6.44±1.24 0.004
Notes: aMann–Whitney U-test. Values shown in bold are statistically significant.
Abbreviations: VAS, visual analog scale; SD, sexual dysfunction; FM, fibromyalgia; 
HDRS, Hamilton Depression Rating Scale; HARS, Hamilton Anxiety Rating Scale; 
stdD, standard deviation.
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Table 4 The distribution of mood and anxiety disorders according to sexual dysfunction
Psychiatric disorders Any sexual  
dysfunction; n (%), 
P-value
Sexual  
desire; n (%), 
P-value
Orgasm  
disorder; n (%), 
P-value
Arousal  
disorder; n (%), 
P-value
Sexual  
aversion; n (%), 
P-value
Dyspareunia; 
n (%), P-value
any mood disorder 16 (34.8) 14 (38.9) 0 2 (20) 0 0
0.164a 0.100a 0.086 0.546a 1.000b 1.000b
MD 14 (30.4) 13 (36.1) 0 1 (10) 0 0
0.082a 0.082a 0.103a 0.222a 1.000b 0.570a
DD 2 (4.3) 1 (2.8) 0 1 (10) 0 0
0.227b 1.000b 0.689a 0.198b 1.000b 1.000a
BPD 0 0 0 0 0 0
– – – – – –
any anxiety disorder 13 (28.3) 11 (30.6) 1 (14.3) 4 (40) 1 (100) 2 (50)
0.022a 0.022a 0.753 0.069a 0.187b 0.158b
gaD 4 (8.7) 2 (5.6) 0 2 (20) 0 2 (50)
1.000b 0.446a 0.407a 0.158a 1.000b 0.034b
PD 2 (4.3) 2 (5.6) 0 0 0 0
0.227b 0.138b 0.689a 1.000b 1.000b 1.000b
saD 2 (4.3) 2 (5.6) 1 1 (10) 0 0
0.227b 0.138b 0.141b 0.198b 1.000b 1.000b
sP 3 (6.5) 3 0 0 0 0
0.106b 0.023b 1.000b 1.000b 1.000b 1.000b
PTsD 0 0 0 0 0 0
– – – – – –
OcD 1 (2.2) 1 (2.8) 0 0 1 (100) 0
1.000b 1.000b 1.000b 1.000b 0.021b 1.000b
NOs anxiety disorder 6 (13) 6 2 (28.6) 2 (20) 0 0
0.010b 0.002b 0.011a 0.058a 1.000b 1.000b
any psychiatric disorder 29 (63) 25 (69.4) 2 (28.6) 6 (60) 0 2 (50)
0.001a 0.001a 0.442b 0.380a 1.000b 1.000b
Comorbidity of any psychiatric  
and any personality disorder
6 (13) 4 (11.1) 0 2 (20) 0 0
0.419a 0.863a – 0.295a – –
Notes: aχ2 test. bFisher’s exact test. Values shown in bold are statistically significant.
Abbreviations: MD, major depression; DD, dysthymic disorder; BPD, bipolar disorder; GAD, generalized anxiety disorder; PD, panic disorder; SAD, social anxiety disorder; 
SP, specific phobia; PTSD, posttraumatic stress disorder; OCD, obsessive–compulsive disorder; NOS, not otherwise specified.
in patients with FM without SD. Pain plays a role in the 
development of SD in patients with rheumatoid arthritis and 
ankylosing spondylitis.8 However, a moderate correlation 
has been suggested between SD and pain in most but not all 
patients with FM,9 whereas sexual function and satisfaction 
reportedly play a minor role.39
One of the most important findings from our study is that 
SD was significantly more frequent in patients with FM and 
any mood or anxiety disorder and that 63% (n=29) of patients 
with FM and SD had a mood or anxiety disorder. The pres-
ence of a mood and anxiety disorder was also significantly 
higher in patients with FM without SD, as compared to the 
control group. No similar study has compared the variables 
that we compared in our study. It has been reported that 
patients with FM and SD have higher depression scores.11,39,40 
Community-based studies indicate that women with SD very 
frequently also have a psychiatric disorder.
Another objective of our study was to understand 
the effects of depression on SD. Tikiz et al12 reported no 
significant difference in the prevalence of SD in patients 
with FM with and without depression. These findings are 
consistent with the findings of our study. Studies report-
ing an association between SD and depression scores are 
available.11,39,40 Depression also plays a role as an independent 
SD variable in patients with FM.39 Studies that have reported 
an association between depression and SD used scales to 
evaluate depressive symptoms rather than evaluating depres-
sion itself.11,39,40 This could be the basis for the differences in 
data obtained between our study and other studies.
An insufficient number of studies have evaluated the 
relationships between anxiety disorders and SD in patients 
with FM. Anxiety disorders are more prevalent and difficult 
to evaluate than depression in community-based study and 
may be less interesting to study.24,41 Although, the prevalence 
of anxiety disorders in FM was higher than other chronic 
pain conditions,42 this is the first study to evaluate SD and 
anxiety disorders separately using the SCID-I in patients 
with FM. Patients with FM and any SD were more likely to 
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exhibit an anxiety disorder or anxiety disorder not otherwise 
specified, as compared to those in the control group in our 
study. No differences were observed in the presence of any 
SD and OCD, GAD, bipolar disorder, specific phobia, panic 
disorder, or posttraumatic stress disorder between the two 
groups. However, patients with FM and sexual aversion dis-
order had a significantly higher incidence of OCD, whereas 
patients with FM and dyspareunia had a significantly higher 
incidence of GAD. Aydin et al11 reported a negative cor-
relation between State-Trait Anxiety Inventory and Female 
Sexual Function Index scores. Our findings are generally 
consistent with published findings.
This is the first study to evaluate the relationship between 
SD and personality disorders in patients with FM using the 
Structured Clinical Interview for DSM, Revised Third Edition 
Personality Disorders. We found no differences in SD between 
patients with FM with and without a personality disorder. 
However, a significant relationship was revealed between 
sexual aversion and avoidance disorders and dependent per-
sonality disorder. No study has examined the relationships 
between personality disorders and SD in patients with FM.
In our study, 46.9% of patients with FM had a mood or 
anxiety disorder, as compared to 5.3% in the control group. 
The prevalence of any psychiatric disorder in patients with 
FM was significantly higher than that in the control group 
used in this study and in the general population.41,43 Our find-
ings are consistent with the 48%–77.3% frequency of Axis I 
disorders reported previously.24,26 We found a mood disorder 
prevalence of 28.1%, whereas that for any anxiety disorder 
was 18.8%. This finding corroborates previously reported 
rates of 19.4%–34.8% for mood disorders and 11.6%–32.2% 
for anxiety disorders.24,26,44 The most common Axis I disor-
ders were major depression (26%) and GAD (8.3%), which 
is consistent with previous studies.26,44 Major depression and 
GAD were observed more frequently in the patient group 
than those in the control group.
A limited number of studies have examined the relation-
ships between patients with FM and personality disorders. 
Thieme et al24 reported an 8.7% prevalence of personality 
disorders using similar diagnostic methods. We determined a 
prevalence of 13.5% in the current study. Uguz et al30 reported 
a 31.1% prevalence of personality disorders, whereas Rose 
et al45 reported a rate of 47.6%. These two figures are consid-
erably higher than the data we obtained. Another difference 
between other studies and ours is the lack of a significant 
difference in personality disorders when comparing patients 
with FM and controls. In our study, only histrionic personality 
disorder (10.4%) was significantly more frequent in the FM 
patient group than that in the control group. Previous studies 
have found that OCD, passive–aggressive personality disor-
der, and avoidant personality disorder are significantly more 
frequent in the patient groups than in the control groups; how-
ever, no such difference was observed in our study. A higher 
diagnostic rate of personality disorders in previous studies 
may be related to clinicians diagnosing personality disorders 
who were not blinded to the fact that the patients also had 
FM. In the current study, the psychiatrists were blinded as 
to whether patients had FM and, therefore, may have shown 
less bias toward a personality disorder diagnosis.
Some limitations of our study should be mentioned. The 
first limitation is the relatively low number of participants. 
Second, no scale was used to assess FM severity. A third lim-
iting factor was that the study was conducted in a university 
hospital setting. We did not consider the marital satisfaction, 
which might be one of the conditions that may affect the 
sexual function. This is another limitation of the study.
Conclusion
SD and mood and anxiety disorders are commonly seen in 
patients with FM. After excluding organic causes of SD, 
pain rather than a mood disorder played a greater role in the 
etiology of SD in patients with FM. Large-scale studies with 
the patient and the control groups examining SD and related 
factors are needed.
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